Enveric Biosciences, Inc. ENVB
NASDAQ Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026
Market cap
$6.36M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
—
EPS growth YoY
93.5%
ROIC
-165.9%
Piotroski F-score
4
Three ways to read the P/E
P/E (GAAP, TTM)
—
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
—
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
—
After-tax operating income only: the core business.
P/E (excl. gains)
—
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | — | — | — | — | — |
| EPS growth YoY (qtr) | 93.5% | 92.6% | +0.9 pts | -213.2% | +306.6 pts |
| Revenue growth (TTM) | — | — | — | — | — |
| EPS growth (TTM) | 95.1% | 90.3% | +4.8 pts | -87.6% | +182.7 pts |
| P/E (GAAP, TTM) | — | — | — | — | — |
| P/E (operating) | — | — | — | — | — |
| P/E (excl. gains) | — | — | — | — | — |
| P/B | 0.12 | 0.11 | +0.01 | — | — |
| ROIC | -165.9% | -165.9% | 0.0 pts | -477.7% | +311.8 pts |
| Net margin | — | — | — | — | — |
| Dividend yield | 0.0% | 0.0% | 0.0 pts | — | — |
| EPS (TTM) | -11.85 | -22.74 | +47.9% | -241.78 | +95.1% |
| Price | $1.49 | $1.39 | +7.2% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | -0.76 | 29.6% | 93.5% | — |
| Mar 31, 2026 | — | — | — | -1.08 | -235.0% | 92.6% | — |
| Dec 31, 2025 * | — | — | — | 0.80 | 107.4% | 100.5% | — |
| Sep 30, 2025 | — | — | — | -10.81 | 7.2% | 74.9% | — |
| Jun 30, 2025 | — | — | — | -11.65 | 20.1% | -213.2% | — |
| Mar 31, 2025 | — | — | — | -14.58 | 91.5% | -58.3% | — |
| Dec 31, 2024 * | — | — | — | -172.45 | -300.1% | -50.4% | — |
| Sep 30, 2024 | — | — | — | -43.10 | -1,058.6% | -3,215.4% | — |
| Jun 30, 2024 | — | — | — | -3.72 | 59.6% | -22.4% | — |
| Mar 31, 2024 | — | — | — | -9.21 | 92.0% | -298.7% | — |
| Dec 31, 2023 * | — | — | — | -114.64 | -8,718.5% | — | — |
| Sep 30, 2023 | — | — | — | -1.30 | 57.2% | 11.0% | — |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 17, 2026 | Date of the latest closing price used. |
| Price | $1.42 | Latest closing price. |
| Market cap | $6.36M | Price × shares outstanding. |
| Enterprise value | $6.36M | Market cap + debt − cash: the price of the whole business. |
| Shares | 4.48M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | — | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | — | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | — | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | — | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | — | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | — | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | — | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | -138.0% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | -834.5% | TTM EPS ÷ price. |
| P/B | 1.52 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | — | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | — | Market cap ÷ revenue of the last four quarters. |
| P/FCF | — | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | — | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | — | Enterprise value ÷ operating income. |
| EV/Sales | — | Enterprise value ÷ revenue. |
| Book value / share | 0.93 | Shareholders' equity ÷ shares. |
| FCF yield | -128.1% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | -1.55 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | $1.71K | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | — | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | $2.46K | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 0.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Jun 30, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | — | Revenue of the latest reported quarter. |
| Net income (qtr) | -$3.03M | Net income of the latest reported quarter. |
| EPS (qtr) | -0.76 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | — | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | — | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | 93.5% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | 29.6% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | -20.2% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | -85.4% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | — | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | — | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | — | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | — | Revenue of the last four quarters. |
| Net income (TTM) | -$8.73M | Net income of the last four quarters. |
| EPS (TTM) | -11.85 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | — | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 95.1% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 12.2% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.0% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | — | Dividends per share paid over the last 12 months. |
| Payout ratio | — | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | — | Dividends ÷ free cash flow. |
| Dividend growth (1y) | — | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | — | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | — | Annualised dividend growth over 5 years. |
| Payments (12m) | — | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | — | Most recent ex-dividend date. |
| Buyback yield | 0.0% | Share repurchases ÷ market cap. |
| Shareholder yield | 0.0% | Dividend yield + buyback yield. |
Profitability
| Gross margin | — | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | — | EBITDA ÷ revenue. |
| Operating margin | — | Operating income ÷ revenue. |
| Net margin | — | Net income ÷ revenue. |
| FCF margin | — | Free cash flow ÷ revenue. |
| ROE | -210.0% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | -172.1% | Return on assets: net income ÷ total assets. |
| ROIC | -165.9% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | — | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | 8.4% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | 84.1% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | — | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | — | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 5.38 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 5.38 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | — | Cash ÷ current liabilities. |
| Debt / equity | 0.00 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.00 | Total debt ÷ total assets. |
| Debt / EBITDA | — | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | — | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | — | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | — | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | -12.4% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | — | Share-based compensation ÷ revenue. |
| R&D % revenue | — | Research & development spending ÷ revenue. |
| SG&A % revenue | — | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 21.0% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | — | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | — | Average days to collect payment from customers. |
| Days inventory | — | Average days inventory is held. |
| Days payables | — | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $16.00 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $1.17 | Lowest price in the last 52 weeks. |
| From 52-week high | -91.1% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 21.4% | How far above the 52-week low the price is. |
| Avg volume (30d) | 26.17K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $38.28K | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 4 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | — | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | — | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | -$8.77M | Net income of the latest fiscal year. |
| Diluted EPS | -36.24 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | -$8.57M | Operating income + depreciation & amortization. |
| Free cash flow | -$8.14M | Operating cash flow − capital spending. |
| Total debt | $0 | Long-term plus current debt. |
| Cash | — | Cash and equivalents. |
| Equity | $4.18M | Shareholders' equity. |
| Total assets | $5.10M | Total assets. |